Skip to main content
v2026.11,986 entries · CC-BY 4.0

GCPP (CASRAI)

Good Clinical Practice Certification: GCP Professional (GCPP)

Examined ICH E6(R3) credential for trial practitioners: 12 modules and a 75-question exam across seven weighted domains, 70% pass mark, valid 3 years. US$279, one-off.

LevelProfessionalGCPGCPP (CASRAI)
7 h
Nominal
Self-paced study
12
Lessons
Self-paced
7
Domains
Exam blueprint
75
Exam items
Per attempt
70%
Pass mark
Fixed, uncurved
90
Retake wait
Days
3 yr
Valid for
From the pass

What you earn

The credential itself

Pass the examination and CASRAI issues this certificate and the post-nominal GCPP (CASRAI), signed by the Programme Director, valid for 3 years, and checkable by anyone from the verification code on its face.

Specimen. Issued as a signed PDF and as a machine-readable Open Badge; the holder and code shown are illustrative.
How it appears on your CV

Certifications

GCPP (CASRAI) — Good Clinical Practice, Professional

CASRAI·Issued Mar 2026·Credential ID CASRAI-GCP-2026-HEYLTT

casrai.org/verify/CASRAI-GCP-2026-HEYLTT

Every certificate is issued under the signature of Dr. Diana Nieves Castro, MD, Programme Director of CASRAI Certification, who sets the syllabus, blueprint and pass mark for this credential.

It certifies that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published on this page — and anyone can confirm it from the verification code, without an account and without contacting us.

About this credential

What it covers

GCPP (CASRAI) is the Professional tier of CASRAI’s Good Clinical Practice credential. It is an examined credential: you study twelve modules built on the ICH E6(R3) Guideline for Good Clinical Practice and the main US, EU and UK trial regulations, then pass a 75-question examination. It is aimed at people who already work in clinical trials and are accountable for other people’s compliance.

Who it is for

  • Lead and senior study coordinators, site managers and research operations managers.
  • Clinical research associates, in-house monitors and the managers who review their reports.
  • Quality assurance and audit staff, and the site or sponsor staff who host regulatory inspections.
  • Sponsor study managers, clinical trial managers and staff who oversee work transferred to service providers.
  • Investigators who supervise a delegation log, not only appear on one.
  • Trainers, SOP authors and institutional GCP programme owners.

If you are new to trials, the Foundation tier, GCPF (CASRAI), has no experience requirement.

What you will be able to do

  • Find any requirement in ICH E6(R3) by its structure, and explain what changed from E6(R2): eleven Principles, Annexes, essential records judged against criteria, and a new data governance section.
  • Decide whether a protocol change needs prior IRB/IEC approval or may be made at once to remove an immediate hazard, and what must be reported afterwards.
  • Assess site feasibility, build a delegation record that shows each delegate is qualified, and handle end of participation, unblinding and safety reporting as the guideline requires.
  • Identify critical-to-quality factors, design proportionate risk-based monitoring, and tell quality assurance, quality control, audit and monitoring apart.
  • Show what real sponsor oversight of a service provider looks like in the records, as opposed to a signed contract and a provider’s own dashboard.
  • Apply the data life cycle and computerised-system requirements: audit trails, corrections, validation, change control and user access.
  • Decide whether a record is essential using the Appendix C criteria, and who keeps the original.
  • Route a serious adverse event correctly, decide whether noncompliance is serious, and set out where US, EU and UK law adds to or differs from ICH.

The twelve modules

  1. How E6(R3) is built and what changed. Scope, the status of the Annexes, the Principles read together, and the move from E6(R2).
  2. Ethics in practice. The 2024 Declaration of Helsinki, the Belmont Report, fair participant selection, vulnerability and therapeutic misconception.
  3. Ethics committees and regulators. IRB/IEC composition and procedures, prior approval and its exceptions, 21 CFR Part 56, the EU application route through CTIS, and the UK framework.
  4. The investigator’s responsibilities. Resources, delegation, protocol compliance, end of participation, investigational product, unblinding, records, and the US Form FDA 1572 and financial disclosure rules.
  5. Quality management and risk-based monitoring. Critical-to-quality factors, risk management, quality tolerance limits, audit and monitoring.
  6. The sponsor’s obligations. Trial design, agreements, service providers, investigator selection, oversight, data monitoring committees and insurance.
  7. Data governance. Blinding in data handling, the data life cycle, audit trail review, corrections, data transfer and retention.
  8. Computerised systems. Validation, change control, release, security, user management, 21 CFR Part 11 and FDA’s 2024 questions-and-answers guidance.
  9. Essential records, the TMF and the ISF. The Appendix C criteria, the Essential Records Table, certified copies and who keeps what.
  10. The protocol, amendments and the Investigator’s Brochure. Appendices A and B, reference safety information and how amendments are handled in the US, EU and UK.
  11. Safety reporting and noncompliance. Adverse event definitions, expedited reporting, immediate hazards, serious noncompliance and corrective and preventive action.
  12. US, EU and UK frameworks compared, and Annex 2. What each jurisdiction’s law requires and how Annex 2 applies to decentralised and pragmatic elements and real-world data.

The examination

  • 75 scored four-option multiple-choice questions per attempt, drawn from a larger question bank so that every attempt follows the domain weights below.
  • Most questions are short scenarios that ask you to apply or analyse a requirement, not to recall a definition.
  • Pass mark: 70%.
  • You must finish the exam within 4 hours of starting it.
  • You must complete all twelve lessons before the examination opens.
  • If you do not pass, you may sit the examination again after 90 days.
Domain Weight
P1 GCP foundations, ethical lineage and the Principles 12%
P2 Governance and oversight: IRB/IEC and regulatory authorities 12%
P3 Investigator responsibilities 18%
P4 Sponsor responsibilities, quality management and oversight 18%
P5 Data governance, source data, ALCOA+ and computerised systems 16%
P6 Essential records, the TMF, the protocol and the Investigator’s Brochure 12%
P7 Safety, noncompliance, and the national frameworks compared 12%

Eligibility

The Foundation tier has no eligibility requirement. For this Professional tier you need to meet one of three routes:

  • Experience: at least 24 months of involvement in interventional clinical trials within the last six years, in a role with responsibilities under ICH E6(R3), such as site coordination, monitoring, sponsor or CRO study management, quality assurance, trial regulatory affairs, investigational pharmacy, clinical data management, pharmacovigilance, or as an investigator or sub-investigator. Part-time work counts at actual hours, with 3,000 hours treated as 24 months.
  • Foundation holder: a current GCPF (CASRAI) plus at least 12 months (or 1,500 hours) of trial involvement within the last four years.
  • Education: an awarded degree, postgraduate diploma or certificate in clinical research, clinical trials or regulatory affairs of at least 60 credit-hours’ equivalent from an accredited institution, plus at least 12 months of trial involvement within the last four years.

Training certificates of any kind, unpaid placements that were part of a degree, and observational or registry work on its own do not count towards these routes. You confirm at checkout that you meet one of the routes; no documents are requested.

What this credential is, and what it is not

GCPP (CASRAI) is an examined credential issued by CASRAI. It shows that you passed an examination set against a published syllabus and domain weights, and an employer can verify with CASRAI that it was issued to you and is current.

It is not accredited by any accreditation body and carries no CE, CME or CEU credit. It does not satisfy any statutory, regulatory, funder, sponsor or institutional requirement for GCP training, so you may still be asked for the GCP training your sponsor or institution requires. It is not issued, endorsed or recognised by ICH, the FDA, EMA, the MHRA or any other regulator, funder or professional body. It does not qualify anyone to practise medicine, nursing or pharmacy, or confer authority to sign a protocol or approve a trial. When you cite it, use the full designation GCPP (CASRAI).

Validity and renewal

A certificate is valid for three years from the date it is issued. To renew it, you pass the examination that is current at the time again. Your course access does not expire, so you can return to the lessons as the standard and the regulations change.

Price

US$279, paid once. Course access does not expire.

Body of knowledge

Exam blueprint

The exam is assembled to these weights on every attempt. They are published before purchase because a blueprint you cannot see is not a blueprint.

Domains and weights7 domains · 75 scored items
DomainWeight
GCP foundations, ethical lineage and the PrinciplesP1
12%9 items
Governance and oversight: IRB/IEC and regulatory authoritiesP2
12%9 items
Investigator responsibilitiesP3
18%14 items
Sponsor responsibilities, quality management and oversightP4
18%13 items
Data governance, source data, ALCOA+ and computerised systemsP5
16%12 items
Essential records, the TMF, the protocol and the Investigator's BrochureP6
12%9 items
Safety, noncompliance, and the national frameworks comparedP7
12%9 items
Total100%

Every attempt has this many items from each domain. The items themselves are drawn at random from the bank within those fixed per-domain quotas, so no two attempts are the same paper.

Syllabus

Syllabus: 12 lessons, 7 hours

Every lesson and every learning outcome is listed. The lesson bodies open on enrolment, and the exam opens once every lesson is marked complete.

12 lessons · 7 h

Lesson material opens once you are enrolled. The full syllabus and every learning outcome are shown here so you can judge the coverage before you pay.

  1. Lesson 1

    Module 2

    1 lesson · 30 min

    1. Locked.Ethics in practice: Helsinki, Belmont and vulnerability30 min · Locked

      On completion you will be able to

      • Apply Helsinki and Belmont reasoning to a case the guideline does not resolve.
      • Evaluate a participant-selection strategy against Principle 1.4, including when its exception applies.
      • Identify vulnerability in a study population and specify proportionate safeguards.
      • Analyse a consent process for therapeutic-misconception and undue-influence risks.
      • Judge whether a placebo-controlled design is permissible under the 2024 Declaration of Helsinki.
  2. Lesson 2

    Module 3

    1 lesson · 30 min

    1. Locked.Ethics committees and regulators: IRB/IEC governance and regulatory interaction30 min · Locked

      On completion you will be able to

      • Assemble an IRB/IEC submission package and check it against 1.2.2.
      • Evaluate a board's composition, quorum and voting record against 1.3.
      • Classify a protocol change as needing prior approval or as permitted immediately, and state the reporting that follows.
      • Explain how a multi-country EU application is assessed under Regulation (EU) No 536/2014.
      • Manage a conditional approval and a lapse in continuing review.
  3. Lesson 3

    Module 4

    1 lesson · 45 min

    1. Locked.The investigator’s responsibilities in depth45 min · Locked

      On completion you will be able to

      • Conduct a feasibility assessment that evidences recruitment potential and resources under 2.2.
      • Build a delegation record that shows each delegate is qualified for each activity.
      • Decide the correct handling of a participant who stops treatment, withdraws or is lost to follow-up, including the data consequences.
      • Perform and document an emergency unblinding to the standard of 2.11.
      • Determine an investigator's reporting obligations for a given event, including protocol-defined endpoint events.
      • Identify the Part 54 financial-disclosure obligations triggered by a described interest.
  4. Lesson 4

    Module 5

    1 lesson · 45 min

    1. Locked.Quality management and risk-based monitoring45 min · Locked

      On completion you will be able to

      • Identify critical-to-quality factors for a given protocol before the trial starts.
      • Evaluate and control identified risks, including setting quality tolerance limits.
      • Distinguish quality assurance, quality control, audit and monitoring by function and independence.
      • Design a risk-based monitoring approach, including the extent of source data verification and review.
      • Evaluate a monitoring plan for proportionality against Principle 7.
  5. Lesson 5

    Module 6

    1 lesson · 30 min

    1. Locked.The sponsor’s obligations: design, agreements, selection and oversight30 min · Locked

      On completion you will be able to

      • Evaluate a trial design against 3.1 and Principle 8.
      • Draft the oversight provisions of a service-provider agreement.
      • Select investigators against defined, documented criteria.
      • Distinguish evidence of contracting and reporting from evidence of sponsor oversight.
      • Set criteria for classifying protocol deviations as important.
  6. Lesson 6

    Module 7

    1 lesson · 45 min

    1. Locked.Data governance and the data life cycle45 min · Locked

      On completion you will be able to

      • Trace a data point from source to analysis data set and identify integrity risks at each transition.
      • Design a risk-proportionate audit-trail review plan.
      • Evaluate a data correction for compliance with 2.12.2, 2.12.6 and 4.2.4.
      • Plan retention, access and destruction across differing national requirements.
      • Assess how blinding is protected in data handling and respond to an inadvertent unblinding.
  7. Lesson 7

    Module 8

    1 lesson · 30 min

    1. Locked.Computerised systems in trials30 min · Locked

      On completion you will be able to

      • Determine whether a system is trial-specific or non-trial-specific and what evidence each needs.
      • Specify a risk-based validation scope for a described system and for a mid-trial change.
      • Evaluate user management and security controls against 4.3.3 and 4.3.8.
      • Plan contingency arrangements for a system failure.
      • Assess a clinical-practice EHR as a trial data source.
  8. Lesson 8

    Module 9

    1 lesson · 30 min

    1. Locked.Essential records, the TMF and the ISF30 min · Locked

      On completion you will be able to

      • Apply the C.3.1 criteria to records that appear on no list.
      • Design a TMF and ISF structure and defend its completeness.
      • Determine which party keeps an original and which a copy, and when a copy may replace an original.
      • Conduct a TMF completeness review against the Essential Records Table.
      • Manage service-provider record access and end-of-trial record transfer.
  9. Lesson 9

    Module 10

    1 lesson · 30 min

    1. Locked.The protocol, amendments and the Investigator’s Brochure30 min · Locked

      On completion you will be able to

      • Review a protocol section by section against Appendix B.
      • Classify an amendment and route it correctly in the US, EU and UK.
      • Assess an Investigator's Brochure for currency and adequacy against Appendix A.
      • Determine expectedness against reference safety information.
  10. Lesson 10

    Module 11

    1 lesson · 30 min

    1. Locked.Safety reporting, immediate hazards and noncompliance30 min · Locked

      On completion you will be able to

      • Classify a safety event and route it correctly to the sponsor, regulators, IRBs/IECs and investigators.
      • Determine expectedness against the Investigator's Brochure's reference safety information.
      • Execute an immediate-hazard response and the reporting that follows.
      • Decide whether noncompliance is serious and design a CAPA that addresses cause.
      • Decide when to terminate a site's participation.
  11. Lesson 11

    Module 12

    1 lesson · 45 min

    1. Locked.US, EU and UK frameworks compared, and Annex 245 min · Locked

      On completion you will be able to

      • Determine which requirements apply to a multi-region trial and where they go beyond ICH.
      • Advise on the submission route for a trial in the US, EU and UK.
      • Distinguish FDA's human-subject regulations from the HHS Common Rule.
      • Explain what Annex 2 adds and when it applies.
      • Design a decentralised element that meets the Principles and national law.
  12. Lesson 12

    Module 1

    1 lesson · 30 min

    1. Locked.How E6(R3) is built, and what changed from E6(R2)30 min · Locked

      On completion you will be able to

      • Locate any requirement in E6(R3) by section, annex or appendix without searching the text.
      • Explain the status of the Annexes and justify an alternative approach by reference to the purpose of a Principle.
      • Determine whether a described study falls within the Guideline Scope.
      • Brief a study team on the structural changes from E6(R2) to E6(R3) and identify SOP content they make obsolete.
      • State the current status of E6(R3) and Annex 2 at ICH, in the EU and at FDA.

Assessment

How the exam works

The exam is closed-book and multiple choice. Each attempt draws a fresh form to the domain weights above, so no two attempts are the same paper and no answer key circulates. The pass mark is 70% and is fixed — there is no curve, no quota and no adjustment by cohort.

Scoring is immediate. Pass, and every item is reviewed with the option you chose, the correct option and its rationale. If you do not pass, you see your overall score and your score per domain (smaller domains are grouped together); which items you missed, and their answers, are held back so your resit is still a real assessment. A failed attempt may be retaken after 90 days. The wait exists so a retake is a second attempt at the material rather than a second attempt at remembering the paper.

The exam opens once you have marked every lesson of the course complete. Forms are assembled to the blueprint above or not at all: where a domain cannot yet be sampled to that standard, the exam declines to start rather than issue an unbalanced paper. Your material and progress are never affected, and there is no time limit on when you sit.

Passing candidates are issued a certificate with a verification code, valid for 3 years from the date of the pass. Anyone can check that code on our public verification page without an account and without contacting us. To renew, pass the current examination again: renewal opens 180 days before the certificate expires, and a pass issues a renewed certificate valid for a further 3 years from that date.

Certifying authority

Signed by Dr. Diana Nieves Castro, MD

CASRAI’s certification programme is academically and medically directed by Dr. Diana Nieves Castro, MD, Programme Director, who sets the syllabus and blueprint for this credential and signs every certificate issued under it.

CASRAI has maintained the terminology and reporting standards of research administration for over a decade. It assumed leadership of the CRediT contributor-roles taxonomy in 2014 and carried it through to adoption as ANSI/NISO Z39.104-2022, now in use by publishers, funders and institutions worldwide. This examination is drawn from that body of work.

What the credential certifies: that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published above. It is valid for 3 years, and anyone can check it from the verification code on its face.

The ladder

Other levels of Good Clinical Practice

Levels are independent purchases. There is no prerequisite chain — sit whichever level matches the work you already do.

GCPF (CASRAI)Foundation

Good Clinical Practice — Foundation

Self-paced online GCP course on ICH E6(R3) with an examination that issues a verifiable GCPF (CASRAI) credential. No experience needed. US$119 once.

Nominal
3.5 h
Lessons
8
Domains
6
Exam items
50
Cut score
70%

All CASRAI credentials

Common questions

Good Clinical Practice Certification: GCP Professional (GCPP): common questions

Does Good Clinical Practice certification expire?

A GCPP (CASRAI) certificate is valid for three years. You renew it by passing the current exam again, and the renewal window opens 180 days before expiry. Course access does not expire, so you can return to the lessons at any time.

How much does good clinical practice certification cost?

GCP Professional costs US$279, a one-time card payment through Stripe checkout. The price covers the 12 lessons and the exam, and course access does not expire. Each certificate has a public verification page at casrai.org/verify/ followed by its code.

What is the GCP Professional exam like?

It is an online exam of 75 four-option multiple-choice questions drawn from the course bank across seven weighted domains, and the pass mark is 70%. The exam opens once all lessons are complete and must be finished within 4 hours of starting. After a failed attempt you can retake it after a 90-day waiting period.

Who is eligible for GCP Professional certification?

You confirm at checkout that you meet one route: 24 months (or 3,000 hours) in interventional trials in the last 6 years, or 12 months (or 1,500 hours) in the last 4 years plus a current GCPF (CASRAI) or a qualifying clinical research, clinical trials or regulatory affairs qualification. This is a self-attestation checkbox; there is no separate application or review.

What is the difference between ICH GCP E6 R2 and R3?

ICH E6(R3) was adopted on 6 January 2025 and replaces E6(R2). It is organised as Principles plus Annexes, with Annex 1 explaining how the 11 Principles apply in practice. It also adds a dedicated section on data governance for investigators and sponsors.

What is the main focus of ICH E6 R3?

E6(R3) aims to protect the rights, safety and well-being of trial participants and to make trial results reliable. It builds on ICH E8(R1) by designing quality into trials, identifying factors critical to quality and using a proportionate, risk-based approach. Its Principles are meant to be flexible, media neutral and applicable to a broad range of clinical trials.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →